MTOR and cancer: Deregulation of the mTOR signaling pathway, including the loss of PTEN function, amplification/mutation of PI3K, and overexpression of S6K1, 4EBP1, eIF4E, and AKT, was described in multiple cancer types but mainly in melanoma [37].